Thanks to lower-than-expected price, ICER backs Amgen's Aimovig—but only after other drugs fail
admin 1st June 2018 Uncategorised 0After learning Aimovig’s official price—$6,900 per year—ICER revised its work to conclude the migraine prevention drug is cost-effective when other options fail.
More: Thanks to lower-than-expected price, ICER backs Amgen's Aimovig—but only after other drugs fail
Source: fierce